Marshall Wace
BDSI

Marshall Wace’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Marshall Wace’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,105,642
Closed -$3.43M – 4434
2021
Q4 		$3.43M Buy
+1,105,642
New +$3.72M 0.01% 1671
2021
Q1 		– Sell
-113,584
Closed -$477K – 3099
2020
Q4 		$477K Sell
113,584
-355,597
-76% -$1.37M ﹤0.01% 1474
2020
Q3 		$1.75M Sell
469,181
-87,358
-16% -$372K 0.01% 843
2020
Q2 		$2.43M Buy
+556,539
New +$2.5M 0.02% 722
2020
Q1 		– Sell
-798,872
Closed -$5.05M – 2296
2019
Q4 		$5.05M Buy
+798,872
New +$4.7M 0.03% 531
2015
Q3 		– Sell
-14,572
Closed -$116K – 1231
2015
Q2 		$116K Sell
14,572
-935,395
-98% -$8.04M ﹤0.01% 849
2015
Q1 		$9.97M Buy
949,967
+95,761
+11% +$1.31M 0.13% 197
2014
Q4 		$10.3M Buy
854,206
+524,208
+159% +$7.97M 0.14% 190
2014
Q3 		$5.64M Buy
329,998
+91,191
+38% +$1.32M 0.08% 270
2014
Q2 		$2.88M Buy
+238,807
New +$2.26M 0.04% 338

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Marshall Wace's BDSI Position: Q1 2022 in Review

Marshall Wace sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,105,642 shares — an estimated $3.43M sold.

Marshall Wace first reported a position in BDSI in Q2 2014 and held it in 10 quarters. The position peaked at $10.3M in Q4 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Marshall Wace reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 1,105,642 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $3.43M.
  • Marshall Wace first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 10 quarters.
  • Marshall Wace's BioDelivery Sciences International, Inc. position peaked at $10.3M in Q4 2014.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.